| Physiologically based pharmacokinetic modeling of monoclonal antibodies in pediatric populations using PK-Sim S Basu, YT Lien, V Vozmediano, JF Schlender, T Eissing, S Schmidt, ... Frontiers in pharmacology 11, 868, 2020 | 30 | 2020 |
| Vancomycin in peritoneal dialysis: clinical pharmacology considerations in therapy E Lam, YT Lien, WK Kraft, B Piraino, V Vozmediano, S Schmidt, J Zhang Peritoneal Dialysis International 40 (4), 384-393, 2020 | 24 | 2020 |
| From cold to hot: changing perceptions and future opportunities for quantitative systems pharmacology modeling in cancer immunotherapy V Lemaire, D Bassen, M Reed, R Song, S Khalili, YT Lien, L Huang, ... Clinical Pharmacology & Therapeutics 113 (5), 963-972, 2023 | 9 | 2023 |
| Applications of advanced natural language processing for clinical pharmacology JC Hsu, M Wu, C Kim, B Vora, YT Lien, A Jindal, K Yoshida, S Kawakatsu, ... Clinical Pharmacology & Therapeutics 115 (4), 786-794, 2024 | 6 | 2024 |
| Investigating clinically adequate concentrations of oseltamivir carboxylate in end-stage renal disease patients undergoing hemodialysis using a population pharmacokinetic approach MA Kamal, KYT Lien, R Robson, V Subramoney, B Clinch, CR Rayner, ... Antimicrobial Agents and Chemotherapy 59 (11), 6774-6781, 2015 | 6 | 2015 |
| Establishment of a Disease‐Drug Trial Model for Postmenopausal Osteoporosis: A Zoledronic Acid Case Study YT Lien, K Madrasi, S Samant, MJ Kim, F Li, L Li, Y Wang, S Schmidt The Journal of Clinical Pharmacology 60, S86-S102, 2020 | 4 | 2020 |
| Identification of new oral dosing regimens for the neuraminidase inhibitor oseltamivir in patients with moderate and severe renal impairment MA Kamal, BJ Brennan, V Subramoney, YT Lien, PN Morcos, N Frey, ... Clinical Pharmacology in Drug Development 4 (5), 326-336, 2015 | 4 | 2015 |
| The quest for balance between capturing data and model complexity: A quantitative clinical pharmacology approach applied to monoclonal antibodies MA Pressly, LA Peletier, S Zheng, VD Sharma, YT Lien, W Wang, H Zhou, ... CPT: Pharmacometrics & Systems Pharmacology 12 (5), 639-655, 2023 | 3 | 2023 |
| Quantitative pharmacology and individualized therapy strategies in development of therapeutic proteins for immune-mediated inflammatory diseases H Zhou, DR Mould John Wiley & Sons, 2019 | 2 | 2019 |
| Concentration QTc analysis of giredestrant: Overcoming QT/heart rate confounding in the presence of drug‐induced heart rate changes L Brooks, M Dolton, J Langenhorst, K Yoshida, YT Lien, V Malhi, C Li, ... Clinical and Translational Science 16 (5), 823-834, 2023 | 1 | 2023 |
| The effect of monoclonal antibodies pharmacokinetics on the tumor cells dynamics: a bifurcation analysis A Hajihosseini, F Maleki, YT Lien, V Vozmediano, S Schmidt JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 45, S45-S46, 2018 | 1 | 2018 |
| Abstract PO4-04-11: Exposure–response analyses of GO39932: a Phase Ia/b study of giredestrant in estrogen receptor-positive, HER2-negative, locally advanced or metastatic … K Jhaveri, YT Lien, N Turner, E Lim, M Cannon, R Anziano, J Langenhorst, ... Cancer Research 84 (9_Supplement), PO4-04-11-PO4-04-11, 2024 | | 2024 |
| UGT1A4 Polymorphism is not Associated with a Clinically Relevant Change in Giredestrant Exposure V Malhi, M Nowicka, YC Chen, P Agarwal, M Waldvogel, YTK Lien, ... Cancer Chemotherapy and Pharmacology, 1-6, 2024 | | 2024 |
| Supplementary Material: The quest for balance between capturing data and model complexity: a quantitative clinical pharmacology approach applied to monoclonal antibodies MA Pressly, LA Peletier, S Zheng, VD Sharma, YTK Lien, W Wang, ... Target 1 (2), 3, 2022 | | 2022 |
| Application of Pharmacometric Principles for Enhanced Decision Making in Special Patient Populations YT Lien University of Florida, 2020 | | 2020 |
| Application of Pharmacometrics and Systems Pharmacology to Current and Emerging Biologics in Inflammatory Bowel Diseases S Ait‐Oudhia, YT Lien, S Basu, L Lesko, S Schmidt Quantitative Pharmacology and Individualized Therapy Strategies in …, 2019 | | 2019 |
| Pharmacokinetics of intraperitoneal vancomycin in patients on automated peritoneal dialysis E Lam, YTK Lien, V Vozmediano, S Schmidt, WK Kraft, J Zhang | | 2019 |
| A STATISTICAL BIOEQUIVALENCE METHOD TO REDUCE SAMPLE SIZE FOR PARALLEL BE STUDY DESIGN: A CASE EXAMPLE FOR LONG-ACTING INJECTABLE DRUGS. Y Lien, M Hu, L Fang, MJ Kim, L Zhao CLINICAL PHARMACOLOGY & THERAPEUTICS 103, S37-S37, 2018 | | 2018 |
| Quantification of postmenopausal osteoporosis population: An system pharmacology approach using bisphosphonates YT Lien, K Madrasi, S Samant, MJ Kim, F Li, S Voss, T Kehoe, L Li, ... JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 44, S120-S120, 2017 | | 2017 |
| Exposure–response analyses of GO39932: a Phase Ia/b study of giredestrant in estrogen receptor-positive, HER2-negative, locally advanced or metastatic breast cancer KL Jhaveri, YTK Lien, NC Turner, E Lim, M Cannon, R Anziano, ... | | |
Stephan SchmidtAssociate Professor of Pharmacy, University of FloridaПотвърден имейл адрес: cop.ufl.edu
